cbdMD, Inc. YCBD announced the closing of its underwritten public offering of 1.35 million shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million.
Maxim Group LLC acted as sole book-running manager for the offering.
The public offering was made pursuant to an effective shelf registration statement on Form S-3, previously filed with the U.S. Securities and Exchange Commission on April 5, 2022 and declared effective on April 21, 2022. The shares of common stock were offered only by means of a prospectus and prospectus supplement that form part of the effective registration statement. A final prospectus supplement describing the terms of the public offering has been filed with the SEC and is available on the SEC's website located at www.sec.gov.
Price Action
cbdMD shares were trading 5.18% higher at $2.03 during Thursday’s pre-market session.
Photo: Benzinga edit with photo by Kindel Media on Pexels
Related News
cbdMD Expands Its Reach To The United Kingdom With Launch On Amazon UK
Wellness Company Milestone: First CBD Brand To Attain Three NSF Certifications For Sports
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!